Lan Peng, MD

Assistant Professor
Pathology

Contact Information

UT Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, Texas 75390

Office Phone: 214-645-3711

lan.peng@utsouthwestern.edu

To make an appointment, call 214-645-8300.

Biography

Dr. Lan Peng received her medical degree from Hunan Medical University in China before she moved to the U.S.   She worked as a researcher at various institutions including the Harvard Medical School and Thomas Jefferson University before resuming her medical training, which include her residency in pathology at New York University during 2003-2007, a surgical pathology fellowship at MD Anderson Cancer Center in Houston in 2007-2008, and a Liver and GI pathology fellowship at Mount Sinai Medical Center in New York in 2008-2009, where she has received specialty training for liver pathology with Drs. Swan Thung and Isabel Fiel, and GI pathology with Dr. Noam Harpaz.  Before joining the University of Texas Southwestern Medical Center in 2011, Dr. Peng spent two years as an Assistant Professor with the University of Massachusetts Medical School. Her primary clinical focus is liver and gastrointestinal pathology. Her research interests include medical liver disease, inflammatory bowel disease and pancreatic neoplasm.  

Education

FellowshipMount Sinai Medical Center, Liver and GI Pathology (2009)
FellowshipMD Anderson Cancer Center, Surgical Pathology (2008)
ResidencyNew York University Hospital, Pathology (2007)
Medical SchoolHunan Medical College (1992)

Research Interests

Medical Liver Disease
Pancreatic Neoplasm
Transplant Liver Pathology

Publications

Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.

Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H, Cancer, 2011 Dec;

High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma.

Peng L, Liang J, Wang H, Song X, Rashid A, Gomez HF, Corley LJ, Abbruzzese JL, Fleming JB, Evans DB, Wang H, Clinical cancer research : an official journal of the American Association for Cancer Research, 2010 Jul; 16 (14):3734-42

Novel PRKAR1A gene mutations in Carney Complex.

Pan L, Peng L, Jean-Gilles J, Zhang X, Wieczorek R, Jain S, Levine V, Osman I, Prieto VG, Lee P, International journal of clinical and experimental pathology, 2010 ; 3 (5):545-8

Vaccination as a triggering event for autoimmune hepatitis.

Perumalswami P, Peng L, Odin JA, Seminars in liver disease, 2009 Aug; 29 (3):331-4

Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas.

Peng L, Wen Y, Han Y, Wei A, Shi G, Mizuguchi M, Lee P, Hernando E, Mittal K, Wei JJ, Fertility and sterility, 2009 Jun; 91 (6):2664-75

Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.

Ward SC, Chang CY, Peng L, Liu LU, Seminars in liver disease, 2009 May; 29 (2):233-7

Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos.

Matsuo K, Galson DL, Zhao C, Peng L, Laplace C, Wang KZ, Bachler MA, Amano H, Aburatani H, Ishikawa H, Wagner EF, The Journal of biological chemistry, 2004 Jun; 279 (25):26475-80

Tissue-specific and ubiquitous promoters direct the expression of alternatively spliced transcripts from the calcitonin receptor gene.

Anusaksathien O, Laplace C, Li X, Ren Y, Peng L, Goldring SR, Galson DL, The Journal of biological chemistry, 2001 Jun; 276 (25):22663-74

Targeted gene repair in mammalian cells using chimeric oligonucleotides.

Kmiec EB, Ye S, Peng L, Genetic engineering, 2000 ; 22:23-31

Analysis of the human RAD51L1 promoter region and its activation by UV light.

Peng L, Rice MC, Kmiec EB, Genomics, 1998 Dec; 54 (3):529-41

Books

Genetic Engineering: Principles and Methods (Targeted gene repair in mammalian cells using chimerical Oligonucleotides.)

Kmiec EB, Ye S and Peng L, Springer (New York, USA) 2001